Drug Trial Radar · NCT02194699
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Last checked: Nov 20, 2026Latest source record: May 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
856
Actual
Start
Oct 30, 2014
Primary completion
May 10, 2017
Study completion Sep 21, 2017
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 18, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist
Conditions
- Uncontrolled Asthma
Interventions
Experimental: TralokinumabBiological
Tralokinumab subcutaneous injection
PlaceboOther
Placebo subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised Asthma Exacerbation Rate (AAER) up to Week 52Time frame: Baseline (Week 0) up to Week 52
Locations
234 sites in 13 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Hoover, Alabama
Research Site
Huntsville, Alabama
Research Site
Scottsdale, Arizona
Research Site
Little Rock, Arkansas
Research Site
Bakersfield, California
Research Site
Buena Park, California
Research Site
Encinitas, California
Research Site
Lakewood, California
Research Site
Lomita, California
Research Site
Northridge, California
Research Site
Palmdale, California
Research Site
Roseville, California
Research Site
Sacramento, California
Research Site
San Francisco, California
Research Site
Thousand Oaks, California
Research Site
Ventura, California
Research Site
Walnut Creek, California
Research Site
Centennial, Colorado
Research Site
Celebration, Florida
Research Site
DeLand, Florida
Research Site
Gainesville, Florida
Research Site
Hialeah, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
New Port Richey, Florida
Research Site
Orlando, Florida
Research Site
Palmetto Bay, Florida
Research Site
Port Charlotte, Florida
Research Site
St. Petersburg, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Columbus, Georgia
Research Site
Gainesville, Georgia
Research Site
Savannah, Georgia
Showing 40 of 234 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.